Coronavirus has caused a lot of adverse effects across the world and research bodies are pulled off efforts to find a vaccine.
AstraZeneca Vaccine remains the only authorised COVID-19 jab in the country after the banned importation of Russian based Sputnik V which was linked with the deputy president William Ruto.
Sad news reaching is the first case of Astrazebeca Associated death after getting the COVID-19 jab.
Deputy Director Of PPB Peter Mbwiiri broke the sad news associating with the demise of man which has raised a lot of tensions among Kenyans who fears for their lives.
Kenyans have reacted to unfortunate news and now will have a don't if to proceed with the vaccination or do away with it and just survive on their own without it.
The pandemic has paralysed the economy of the country and Kenyans will have to take caution and observe the set protocols and measures to prevent the situation from escalating to worse state.
Content created and supplied by: Mutuoth (via Opera
News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform
See More
COMMENTS